Current Assets
Total Current Assets
Bristol-Myers Squibb Total Current Assets decreased by 7.4% to $27.21B in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 11.6%, from $30.78B to $27.21B. Over 5 years (FY 2020 to FY 2025), Total Current Assets shows relatively stable performance with a -0.5% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
Analysis
StatementBalance Sheet Statement
SectionCurrent Assets
CategoryLiquidity
SignalHigher is better
VolatilityModerate
First reportedQ4 2014
Last reportedQ1 2026Apr 30, 2026
How to read this metric
Higher levels indicate strong short-term liquidity and the ability to cover immediate liabilities.
Detailed definition
This is the aggregate value of all assets that are reasonably expected to be converted into cash, sold, or consumed with...
Peer comparison
Used to calculate the current ratio, which is a standard benchmark for financial stability among pharmaceutical peers.
Metric ID:
total_current_assetsHistorical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $29.16B | $31.44B | $33.26B | $30.12B | $30.19B | $26.8B | $27.27B | $27.09B | $28.07B | $27.63B | $31.77B | $28.67B | $26.89B | $28.08B | $29.78B | $30.78B | $33.22B | $35.63B | $29.39B | $27.21B |
| QoQ Change | — | +7.8% | +5.8% | -9.4% | +0.2% | -11.2% | +1.8% | -0.7% | +3.6% | -1.6% | +15.0% | -9.8% | -6.2% | +4.4% | +6.1% | +3.4% | +7.9% | +7.2% | -17.5% | -7.4% |
| YoY Change | — | — | — | — | +3.5% | -14.8% | -18.0% | -10.1% | -7.0% | +3.1% | +16.5% | +5.8% | -4.2% | +1.6% | -6.3% | +7.4% | +23.5% | +26.9% | -1.3% | -11.6% |
Range$26.8B – $35.63B
CAGR-1.4%
Avg YoY Growth+0.9%
Median YoY Growth+0.1%
Current Streak2 quarters decline
Total Current Assets at Other Companies
Frequently Asked Questions
- What is Bristol-Myers Squibb's total current assets?
- Bristol-Myers Squibb (BMY) reported total current assets of $27.21B in Q1 2026.
- How has Bristol-Myers Squibb's total current assets changed year-over-year?
- Bristol-Myers Squibb's total current assets decreased by 11.6% year-over-year, from $30.78B to $27.21B.
- What is the long-term trend for Bristol-Myers Squibb's total current assets?
- Over 5 years (2020 to 2025), Bristol-Myers Squibb's total current assets has grown at a -0.5% compound annual growth rate (CAGR), from $30.19B to $29.39B.
- What does total current assets mean?
- The sum of all assets the company expects to turn into cash within one year.